Side-by-side financials for COYA and MRK. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COYA | MRK |
|---|---|---|
| Market cap | - | $298.26 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $7.95M | $65.01B |
| Net income (latest FY) | -$21.23M | $18.25B |
| Net margin | -267.1% | 28.1% |
| P/E (trailing FY) | - | 16.3 |
| SEC filings | 222 | 996 |
In their latest fiscal years, Coya Therapeutics, Inc. reported $7.95M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Coya Therapeutics, Inc. and Merck & Co., Inc., or browse the full rankings.